Scientific Reports · Nov 17, 2026

Triglyceride glucose body mass index and incident cardiometabolic multimorbidity among middle and older adults in China and England

By Zheng J, Wang X, Lv Z et al.

Cardiometabolic multimorbidity (CMM) substantially reduces life expectancy, and the triglyceride-glucose body mass index (TyG-BMI) is a simple marker of insulin resistance. We examined the prospective association between TyG-BMI and incident CMM in the China Health and Retirement Longitudinal Study (CHARLS; primary cohort, n = 6,426) and the English Longitudinal Study of Ageing (ELSA; replication cohort, n = 2,221). CMM was defined as at least two of diabetes, hypertension, heart disease, and stroke in CHARLS, and of diabetes, heart disease, and stroke in ELSA, where harmonized hypertension data were unavailable. Incident CMM occurred in 17.8% of CHARLS and 2.9% of ELSA participants. In fully adjusted logistic models, the highest versus lowest TyG-BMI quartile was associated with higher odds of CMM in CHARLS (OR = 5.72, 95% CI 4.52–7.22) and ELSA (OR = 4.03, 95% CI 1.70–11.16). In CHARLS, the association persisted after adjustment for the number of baseline CMM components (OR = 4.02, 95% CI 3.15–5.14), among participants with zero or one baseline component, and after restriction to complete baseline ascertainment; the corresponding risk ratio was 3.91 (95% CI 3.23–4.73). Discrimination was modest (AUC 0.655). The direction of association was replicated across cohorts, but effect magnitudes are not directly comparable, and clinical predictive utility requires dedicated evaluation.

doi.org/10.1038/s41598-026-81037-4Open accessBiomarkers

AgingResearch.News